AGREEMENT AND PLAN OF MERGER BY AND AMONG ARTHROCARE CORPORATION, OC MERGER SUB CORPORATION, OC ACQUISITION SUB LLC, OPUS MEDICAL, INC. AND JAMES W. HART AND STEVEN L. GEX, AS SHAREHOLDERS’ AGENTS DATED AS OF SEPTEMBER 3, 2004Agreement and Plan of Merger • November 18th, 2004 • Arthrocare Corp • Electromedical & electrotherapeutic apparatus • California
Contract Type FiledNovember 18th, 2004 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER, dated as of September 3, 2004 (this “Agreement”), is made by and among ArthroCare Corporation, a Delaware corporation (“Parent”), OC Merger Sub Corporation, a California corporation and a wholly owned subsidiary of Parent (“Merger Sub I”), OC Acquisition Sub LLC, a California limited liability company (“Merger Sub II” and, together with Merger Sub I, “Merger Subs”), Opus Medical, Inc., a California corporation (the “Company”), and for purposes of Articles 3, 8 and 11, James W. Hart and Steven L. Gex, as the Shareholders’ Agents (each, a “Shareholders’ Agent” and, together, the “Shareholders’ Agents”).
AGREEMENT AND PLAN OF MERGER BY AND AMONG ARTHROCARE CORPORATION, OC MERGER SUB CORPORATION, OC ACQUISITION SUB LLC, OPUS MEDICAL, INC. AND JAMES W. HART AND STEVEN L. GEX, AS SHAREHOLDERS’ AGENTS DATED AS OF SEPTEMBER 3, 2004Agreement and Plan of Merger • September 9th, 2004 • Arthrocare Corp • Electromedical & electrotherapeutic apparatus • California
Contract Type FiledSeptember 9th, 2004 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER, dated as of September 3, 2004 (this “Agreement”), is made by and among ArthroCare Corporation, a Delaware corporation (“Parent”), OC Merger Sub Corporation, a California corporation and a wholly owned subsidiary of Parent (“Merger Sub I”), OC Acquisition Sub LLC, a California limited liability company (“Merger Sub II” and, together with Merger Sub I, “Merger Subs”), Opus Medical, Inc., a California corporation (the “Company”), and for purposes of Articles 3, 8 and 11, James W. Hart and Steven L. Gex, as the Shareholders’ Agents (each, a “Shareholders’ Agent” and, together, the “Shareholders’ Agents”).